Article info
PDFOesophagus
Original article
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
- Correspondence to Dr Richard C Turkington, Centre for Cancer Research and Cell Biology, Queen’s University Belfast, Belfast, BT9 7BL, UK; r.turkington{at}qub.ac.uk
Citation
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma
Publication history
- Received September 19, 2018
- Revised February 13, 2019
- Accepted February 15, 2019
- First published March 9, 2019.
Online issue publication
November 22, 2019
Article Versions
- Previous version (7 October 2019).
- Previous version (7 October 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.